Navigation Links
NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
Date:4/8/2008

HUBBARD, Ohio, April 8, 2008 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC Pink Sheets: NNLX) a nano-biotechnology company announces publication of 2007 financial data and a director appointment.

NanoLogix has posted 2007 unaudited financials. 2007 expenditures were reduced by 42% over 2006, while funding for 2007 Research and Development was increased by 19%. The information can be accessed at: http://www.nanologixinc.com/financials.html

NanoLogix welcomes Bert Pharis to the Board of Directors. Mr. Pharis was formerly President and CEO of Sygnet Wireless, a Cellular Telephone Company in Northeastern Ohio and Western Pennsylvania, from the mid-Eighties until Sygnet's 1998 sale to Dobson Communications. Mr. Pharis then served as a Director of Dobson Communications, sitting on both the Audit and Compensation Committees, through the 2007 sale of Dobson to AT&T. He was President and CEO of Logix Communications, a Competitive Local Exchange Carrier operating primarily in Texas and Oklahoma, from 1999 through 2001. Following that he spent two years as President and CEO of Ortheon Medical, a Medical Device Company in Orlando, Florida.

Bret Barnhizer, CEO of NanoLogix stated, "Bert Pharis is a welcome addition to our new Board of Directors, bringing extensive corporate business expertise in addition to experience with the processes involved in obtaining FDA approval for medical devices."

About NanoLogix, Inc.

NanoLogix is a leading innovator in the research, development, and commercialization of nano-biotechnologies, applications and processes. The Company has 31 granted Patents and multiple Patents Pending for bioreactor- based Hydrogen Production, revolutionary rapid medical testing technologies, and bioremediation. Information on NanoLogix is available at http://www.nanologixinc.com .

This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact:

Investor Relations

Bret Barnhizer, CEO

Telephone: 330-534-0800

E-mail: Bret@nanologixinc.com


'/>"/>
SOURCE NanoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
2. National Public Radio (NPR) Features Broadcast Articles on NanoLogix Hydrogen Bioreactor Operation at Welchs Foods
3. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
4. NanoLogix, Inc. Makes Stock Pick List
5. NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update
6. NanoLogix Inc. to Present at EBW Expo & Conference 2007
7. NanoLogix Inc. Announces Historical First in Energy Generation With Bioreactor-Produced Hydrogen at Welchs
8. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
9. Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research
10. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
11. SGX Pharmaceuticals Provides Update on SGX523 Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 2017 , ... Crucial Data Solutions (CDS) is excited to ... unified. TrialKit, a native mobile app, empowers investigators and clinicians to build, deploy, ... mobile devices. With TrialKit, clinical researchers can utilize Core Motion technologies and Apple’s ...
(Date:7/18/2017)... ... July 18, 2017 , ... Blood centers traditionally see a ... region. Nationally, summer is a struggle for community blood centers as high schools are ... Antonio Chamber of Commerce is teaming up with the South Texas Blood ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... solutions, today announced safety software company AB Cube has joined its ... segment to advance technology innovation across life sciences and healthcare. Under the ...
(Date:7/17/2017)... , ... July 17, 2017 , ... ... its long-standing innovation strategy. A website (openinnovation.pioneer.com) dedicated to connecting third-party ... areas – trait discovery, plant breeding, enabling technologies, biologicals and digital solutions. , ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
Breaking Biology News(10 mins):